Hypertension Diagnostics, Inc. Provides a Shareholders Update

Hypertension Diagnostics, Inc. (OTC: HDII) the CEO Long Bo is pleased to announce  China Specialty International Limited had a conference meeting with Zhang Jin, Domestic Marketing Vice President of Sonsea Foods Co, Ltd, regarding the Co-branding Partnership in Chili Sauce related products on April 20,2021.
The Co-brands are planned to be used in Sonsea Foods Co’s products and distribution chain.
Sonsea Foods Co, Ltd VP Zhang Jin said they would like to have the opportunities co-operated with
USA public listing company HDII. He introduced that Sonsea Foods Co, Ltd owned 38 patents, and is  one of China Top 100 Enterprises in Aquatic Products Freezing Processing. Their products include 5 series of over 200 kinds of organic green food, including freshwater crayfish, freshwater fish  and vegetables, which are exported to more than 30 countries and regions such as Europe, the United States, Japan, South Korea, and Hong Kong. There are 108 sales outlets, 4 representative offices, and 1 overseas sales center in China.

Sonsea Foods Co, Ltd
The Sonsea Foods Co, Ltd (http://www.sonsea.cc) owns a 100,000 square meters manufactory,
with total assets of 420 million RMB, and 480 staffs. It has production lines for processing
crayfish, freshwater fish, turtles, vegetables, and fodder, with a cold storage capacity of 20,000
tons and a daily quick-freezing capacity of 180 tons. It has 4,800 mu of breeding base and a
national reserve base of more than 200,000 mu(1 ACRE=15 MU).
The Sonsea Foods Co, Ltd has Passed the national import and export inspection and quarantine
sanitation registration, obtained the US FDA, EU EEC, UK BRC global food standard
certification, passed ISO9001: 2008 international quality management system, ISO22000: 2005
food safety management system certification, HACCP certification, green food and CNAS
organic food certification. The company's "Fisher girl" brand has been recognized as "China's
Well-known Trademark" and "Hunan International Well-known Brand".
China Specialty (Hong Kong) International Limited
China Specialty International Limited is established in 2007 and its founder Mr. Bo
Long has over 25 years of experience related to traditional condiments and fast-
moving consumer goods (FMCG) production. Between 2003 to 2013, as a Co-
founder, Mr. Bo Long helped Guangzhou Texian Food Co., Ltd. (the brand Xian Ge
http://www.gztxfood.com) to achieve nearly 1 billion RMB of annual turnover from the
start-up. Between 2006 to 2019, Mr. Bo Long had invested 50 million RMB in two
Chinese food processing plants, through which he had accumulated rich investment
and management experience in the whole industry chain of condiments and FMCG
products.

China Specialty International Limited holds and maintains more than 30 registered
trademarks which Mr. Bo Longs business and production relates to. As a holding
company, China Specialty International Limited focuses on brand licensing,
distribution authorization and investment related to these registered brands and
trademarks in provincial-level, city-level, country-level administrative regions in
China.
Hypertension Diagnostics, Inc.
Hypertension Diagnostics, Inc (OTC: HDII), is a public company currently trading on
the OTC Markets (HDII). HDII was originally incorporated in MN.
*Safe Harbor Statement Information in this press release may contain forward-
looking statements.Statements describing objectives or goals or the Company's
future plans are also forward-looking statements and are subject to risks and
uncertainties, including the financial performance of the Company and market
valuations of its stock, which could cause actual results to differ materially from those
anticipated. Forward-looking statements in this news release are made pursuant to
the Safe Harbor; provisions of the United States Private Securities Litigation Reform
Act of 1995. Investors are cautioned that such forward-looking statements involve
risks and uncertainties, including, without limitation, risks relating to the ability to
close transactions being contemplated, risks related to sales, acceptance of
Hypertension Diagnostics, Inc products, increased levels of competition, changes,
dependence on intellectual property rights and other risks detailed from time to time
in Hypertension Diagnostics, Inc. periodic reports filed with the regulatory.
SOURCE: Hypertension Diagnostics, Inc
Investor Information: [email protected]